{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 29639
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10005945",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "receivedateformat": "102",
      "receivedate": "20140313",
      "receiptdateformat": "102",
      "receiptdate": "20140313",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-JNJFOC-20140302898",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "JANSSEN",
        "duplicatenumb": "US-JNJFOC-20140302898"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "32",
        "patientonsetageunit": "801",
        "patientweight": "99.79",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Diabetic ketoacidosis",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Influenza",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Treatment noncompliance",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "INVOKANA",
            "drugbatchnumb": "UNKNOWN",
            "drugauthorizationnumb": "204042",
            "drugstructuredosagenumb": "300",
            "drugstructuredosageunit": "003",
            "drugdosageform": "TABLET",
            "drugadministrationroute": "048",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "actiondrug": "1",
            "drugrecurreadministration": "2",
            "openfda": {
              "application_number": [
                "NDA204042"
              ],
              "brand_name": [
                "INVOKANA"
              ],
              "generic_name": [
                "CANAGLIFLOZIN"
              ],
              "manufacturer_name": [
                "Janssen Pharmaceuticals, Inc."
              ],
              "product_ndc": [
                "50458-140",
                "50458-141"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "CANAGLIFLOZIN"
              ],
              "rxcui": [
                "1373463",
                "1373469",
                "1373471",
                "1373473"
              ],
              "spl_id": [
                "30ca5702-272c-7528-e063-6294a90abbc1"
              ],
              "spl_set_id": [
                "b9057d3b-b104-4f09-8a61-c61ef9d4a3f3"
              ],
              "package_ndc": [
                "50458-140-30",
                "50458-140-90",
                "50458-140-50",
                "50458-140-10",
                "50458-140-01",
                "50458-141-30",
                "50458-141-90",
                "50458-141-50",
                "50458-141-10",
                "50458-141-01"
              ],
              "unii": [
                "0SAC974Z85"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "INSULIN",
            "openfda": {
              "brand_name": [
                "INSULIN 1556"
              ],
              "generic_name": [
                "INSULIN"
              ],
              "manufacturer_name": [
                "Professional Complementary Health Formulas"
              ],
              "product_ndc": [
                "63083-1556"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "INSULIN GLARGINE"
              ],
              "spl_id": [
                "c3c5ae59-b449-474d-8b9c-80f1e5e4eb7b"
              ],
              "spl_set_id": [
                "88170080-374d-456e-90bc-48e873878ce7"
              ],
              "package_ndc": [
                "63083-1556-1"
              ],
              "nui": [
                "M0011417",
                "N0000175453"
              ],
              "pharm_class_cs": [
                "Insulin [CS]"
              ],
              "pharm_class_epc": [
                "Insulin Analog [EPC]"
              ],
              "unii": [
                "2ZM8CX04RZ"
              ]
            }
          }
        ]
      }
    }
  ]
}